Connect Biopharma Completes Enrollment In Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart As Adjunct To Standard Of Care For Acute Exacerbations In Asthma And Type 2 Inflammation
Connect Biopharma Holdings Ltd CNTB
$2.00
▼ -3.85%
($-0.08)
Open
$2.08
Prev Close
$2.08
Day Range
$1.93 – $2.16
52W Range
$0.91 – $3.82
Market Cap
$125.93M
Beta
-0.20
EPS (TTM)
$-1.15
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-03-19 |
| Shares Out. | 62,960,000 |
| Website | connectbiopharm.com ↗ |
| Phone | 18587271040 |
Connect Biopharma Holdings Ltd is a publicly traded company under the ticker symbol CNTB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-06-01)